AlphAIalphai — Financial news for AI agents
simplywall.stAUG 282 min read$ACHC

Acadia Healthcare Company (ACHC) After Strong Q2 And Higher Outlook Looks Modestly Undervalued

Acadia Healthcare (ACHC) reported Q2 earnings above estimates, driven by higher patient admissions. The stock has surged 30.26% over 90 days and 111.48% year-to-date, but long-term returns remain negative. Analysts suggest the stock is modestly undervalued at $30.22, with a fair value estimate of $32.21, citing growth prospects and operational leverage. However, risks include Medicaid reimbursement pressures and legal costs.

Original reporting
simplywall.st
Published Aug 28, 2026, 2:43 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 7:37 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Acadia Healthcare Company (ACHC) After Strong Q2 And Higher Outlook Looks Modestly Undervalued — source image
Source · simplywall.st
Decision brief

The 30-second read

$ACHCBullishLow
01

Why it matters

The earnings beat could prompt price appreciation toward the $32.21 target, though long‑term return metrics are still weak.

02

Market read

Earnings beat offers a modest upside catalyst for ACHC and signals health‑sector resilience.

03

What to watch

Potential regulatory cost pressures and long‑term shareholder return trends remain negative.

Relevance 4/10Novelty 2/10Timing: post‑earnings release

Background

Acadia Healthcare Company (ACHC) reported Q2 results ahead of estimates, with higher admissions and a fair‑value gap.

Company-level read

Ticker impact

$ACHCBullishMedium confidence
Context

Q2 earnings beat consensus estimates, driven by higher patient admissions and demand for behavioral health services.

Expected impact

Potential short‑term rally of 5‑7% as the market re‑prices the earnings beat.

Evidence & confidence

Earnings beat indicates revenue growth momentum, but Medicaid reimbursement risk tempers upside.

Market effects

Sector

Highlights strength and valuation potential in the behavioral‑health sector.

Regional

May boost investor interest in US healthcare stocks.

Global

Limited to US market; modest effect on broader global equities.

Counterpoint

What could challenge this read

Valuation gap may reflect lingering Medicaid reimbursement concerns that could outweigh earnings beat.

Key entities

  • company
    Acadia Healthcare Company

    US‑listed behavioral health services provider (ticker ACHC).

Read at source← All news

Related articles

JUL 30
$ACHCMedAI 8/10

Acadia Healthcare Q2 Earnings Call Highlights

Acute care: Revenue was $495 million, flat year over year but up 6% after normalizing for supplemental payments. Management cited strong volumes and admissions at existing acute facilities as well as newer joint-venture and de novo locations. Specialty care: Revenue was $134 million, up 4% sequentially from the first quarter. The business experienced the full-quarter impact of the New York Medicaid decision.

yahoo.com6 min
JUL 28
$ACHCMedAI 8/10

Acadia Healthcare: Q2 Earnings Snapshot

Acadia Healthcare Co. (ACHC) reported Q2 net income of 12 cents per share and adjusted earnings of 38 cents per share, versus a Zacks mean estimate of 33 cents. Revenue was $865.8 million, above the $844.7 million forecast. Full-year guidance calls for EPS of $1.45 to $1.60 and revenue of $3.4 billion to $3.45 billion.

local3news.com2 min
JUL 28
$ACHCMed

Acadia Healthcare (NASDAQ:ACHC) Posts Better

Acadia Healthcare (NASDAQ:ACHC) reported Q2 CY2026 revenue of $865.8 million, flat year on year but above expectations by about 2%, and non-GAAP adjusted EPS of $0.38, down from $0.83 but 9.7% above consensus. The company guided full-year revenue to about $3.43 billion. Shares fell about 1.3% to $32.18 after the report.

financialcontent.com6 min
JUL 28
$ACHCMed

Acadia Healthcare Company, Inc. (ACHC): Results of Operations and Financial Condition

Acadia Healthcare Company, Inc. (ACHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_994474.htm EXHIBIT 99.1 ex_994474.htm Exhibit 99.1 ACADIA HEALTHCARE ANNOUNCES SECOND QUARTER 2026 RESULTS AND UPDATES FULL YEAR 2026 FINANCIAL AND CASH FLOW GUIDANCE FRANKLIN, Tenn. (July 28, 2026 ) – Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASD

SEC EDGAR 8-K4 min
AUG 28
$GOOGHighAI 8/10

Sundar Pichai Raised Alphabet's 2026 Capex Forecast to as Much as $205 Billion, Sending the Stock Down 7%. Was That an Overreaction That Investors Should Buy Into?

Alphabet (GOOG, GOOGL) raised its 2026 capital expenditure forecast to $195B-$205B, up from $180B-$190B, causing its stock to drop 7%. The company aims to invest in AI and cloud infrastructure to meet high demand, despite being free-cash-flow negative in Q2. Alphabet's P/E ratio is near its lowest, and it reported an 82% YoY increase in cloud revenue.

aol.com4 min